Axitinib for the treatment of advanced non-small-cell lung cancer

By King Judy W  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 765-773

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer

By Spano Jean-Philippe  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1531-1539

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments

By Locati Laura D.   Licitra Lisa   Agate Laura   Ou Sai-Hong I.   Boucher Andree   Jarzab Barbara   Qin Shukui   Kane Madeleine A.   Wirth Lori J.   Chen Connie   Kim Sinil   Ingrosso Antonella   Pithavala Yazdi K.   Bycott Paul   Cohen Ezra E. W.  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2694-2703

Blackwell Publishing

Access to resources Recommend Favorite

Reovirus-based therapy promising for advanced solid tumours

By  

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

A phase I study of temsirolimus and metformin in advanced solid tumours

By MacKenzie Mary  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 647-652

Springer Publishing Company

Access to resources Recommend Favorite